However, for tumors with high levels of immune infiltration, we found a trend towards higher expression of neoantigen presenting genes [23] for patients responding to chemotherapy compared to non-responders (p = 0.069; Wilcoxon rank-sum test; Fig. 4j).
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}